S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD). (31st January 2022) - Kanter, J; Shah, A; Joshi, V; Mehta, H; Levine, M; Arunagiri, U; Paulose, J; Donohue, B; Scalera, A; Manwani, D